Salvage surgery in recurrent sinonasal cancers : Proposal for a prognostic model based on clinicopathologic and treatment-related parameters
© 2022 The Authors. Head & Neck published by Wiley Periodicals LLC..
BACKGROUND: Evidence on survival and major prognosticators after salvage surgery in recurrent sinonasal cancers (SNC) is limited.
METHODS: A retrospective, single-center study of recurrent SNC treated with salvage surgery between 1997 and 2019 was conducted. Univariate and multivariable analyses were performed to define a prognostic score for overall survival (OS).
RESULTS: One hundred and eighteen patients were included. Recurrent SNC originated mostly in the naso-ethmoidal box (67.8%) and were mainly epithelial (76.2%), high-grade (49.2%), and locally advanced (rpT4, 60.1%) malignancies. Negative margins were achieved in 56.6% of cases. Two- and 5-year OS were 71.7% and 56%, respectively. The prognostic model included treatment modality for primary tumor, histology, rpT class, margin status, perineural invasion, and adjuvant radiotherapy and stratified patients into three prognostic groups (5-year OS: 84.4%, 44.9%, and 0%, respectively).
CONCLUSIONS: Treatment of recurrent SNC can result in good long-term survival estimates with limited morbidity. Our score can provide excellent prognostic stratification.
Errataetall: |
CommentIn: Head Neck. 2023 Feb;45(2):537-539. - PMID 36394120 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
---|---|
Enthalten in: |
Head & neck - 44(2022), 8 vom: 01. Aug., Seite 1857-1870 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mattavelli, Davide [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 07.07.2022 Date Revised 16.02.2023 published: Print-Electronic CommentIn: Head Neck. 2023 Feb;45(2):537-539. - PMID 36394120 Citation Status MEDLINE |
---|
doi: |
10.1002/hed.27102 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM341743933 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM341743933 | ||
003 | DE-627 | ||
005 | 20231226012458.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/hed.27102 |2 doi | |
028 | 5 | 2 | |a pubmed24n1139.xml |
035 | |a (DE-627)NLM341743933 | ||
035 | |a (NLM)35652409 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mattavelli, Davide |e verfasserin |4 aut | |
245 | 1 | 0 | |a Salvage surgery in recurrent sinonasal cancers |b Proposal for a prognostic model based on clinicopathologic and treatment-related parameters |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.07.2022 | ||
500 | |a Date Revised 16.02.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Head Neck. 2023 Feb;45(2):537-539. - PMID 36394120 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 The Authors. Head & Neck published by Wiley Periodicals LLC. | ||
520 | |a BACKGROUND: Evidence on survival and major prognosticators after salvage surgery in recurrent sinonasal cancers (SNC) is limited | ||
520 | |a METHODS: A retrospective, single-center study of recurrent SNC treated with salvage surgery between 1997 and 2019 was conducted. Univariate and multivariable analyses were performed to define a prognostic score for overall survival (OS) | ||
520 | |a RESULTS: One hundred and eighteen patients were included. Recurrent SNC originated mostly in the naso-ethmoidal box (67.8%) and were mainly epithelial (76.2%), high-grade (49.2%), and locally advanced (rpT4, 60.1%) malignancies. Negative margins were achieved in 56.6% of cases. Two- and 5-year OS were 71.7% and 56%, respectively. The prognostic model included treatment modality for primary tumor, histology, rpT class, margin status, perineural invasion, and adjuvant radiotherapy and stratified patients into three prognostic groups (5-year OS: 84.4%, 44.9%, and 0%, respectively) | ||
520 | |a CONCLUSIONS: Treatment of recurrent SNC can result in good long-term survival estimates with limited morbidity. Our score can provide excellent prognostic stratification | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a prognostic score | |
650 | 4 | |a recurrence | |
650 | 4 | |a salvage surgery | |
650 | 4 | |a sinonasal cancer | |
650 | 4 | |a survival | |
700 | 1 | |a Tomasoni, Michele |e verfasserin |4 aut | |
700 | 1 | |a Ferrari, Marco |e verfasserin |4 aut | |
700 | 1 | |a Compagnoni, Alessandra |e verfasserin |4 aut | |
700 | 1 | |a Schreiber, Alberto |e verfasserin |4 aut | |
700 | 1 | |a Taboni, Stefano |e verfasserin |4 aut | |
700 | 1 | |a Rampinelli, Vittorio |e verfasserin |4 aut | |
700 | 1 | |a Marazzi, Elisa |e verfasserin |4 aut | |
700 | 1 | |a Raffetti, Elena |e verfasserin |4 aut | |
700 | 1 | |a Redaelli de Zinis, Luca Oscar |e verfasserin |4 aut | |
700 | 1 | |a Deganello, Alberto |e verfasserin |4 aut | |
700 | 1 | |a Maroldi, Roberto |e verfasserin |4 aut | |
700 | 1 | |a Bossi, Paolo |e verfasserin |4 aut | |
700 | 1 | |a Piazza, Cesare |e verfasserin |4 aut | |
700 | 1 | |a Nicolai, Piero |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Head & neck |d 1996 |g 44(2022), 8 vom: 01. Aug., Seite 1857-1870 |w (DE-627)NLM012791806 |x 1097-0347 |7 nnns |
773 | 1 | 8 | |g volume:44 |g year:2022 |g number:8 |g day:01 |g month:08 |g pages:1857-1870 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/hed.27102 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 44 |j 2022 |e 8 |b 01 |c 08 |h 1857-1870 |